Recently, Marc Beer was named LumeN XT, Inc.’s Chairman of the Board. LumeN XT is an established private company which has been creating proprietary surgical illumination products to streamline minimally invasive surgeries. Beer is a highly experienced entrepreneur and medical professional. He has over 25 years of experience developing and commercializing in several fields including pharmaceuticals, biotechnology, diagnostics and devices.
After the appointment, Marc Beer said that it was a proud moment for him and he felt privileged to work with a committed and successful group of both engineers and surgeons who have spearheaded many advancements in the field of surgical illumination. The group of engineers and surgeons played a huge role in the development of the LumeN XT proprietary technology promoting safe surgeries. Marc Beer believes that the significance of LumeN XT platform will continue to increase as more surgeons leverage minimally invasive approaches to perform surgeries.
The technology has been in use for quite some time. The surgeons who have had the privilege of using targeted illumination testify to the enhancements in precision, visualization and flexibility it comes with. LumeN XT provides a platform which is used to reduce heat during surgeries improving low-cost disposable options, surgical precision, and safety.
Paul Rhyne, LumeNXT Co-Founder, praised Marc Beer for his success in the healthcare sector. He has demonstrated a leadership style that has helped startups to sail through to success. He has started, established and helped many startups to grow through multiple growth phases. His experience helping companies to expand globally and along the path of profitability is unmatched. The experience and expertise he brings on board will be highly valuable to his new company.
Marc Beer is the current CEO of Renovia, Inc., a women’s health startup he founded to address pelvic floor disorders in women across the world. The health company develops therapeutic and diagnostic products for more than 250 million women around the world who suffers from pelvic floor disorders.
Prior to starting Renovia, Inc., Marc Beer served as Minerva Neurosciences Inc.’s Founding Chairman. Minerva Neurosciences is a leading clinical-stage biopharmaceutical company which develops products for the treatment of central system diseases. It is performing several late-stage clinical trials and developing products for insomnia and mood disorders, schizophrenia, Parkinson’s Disease and major depressive disorders.
Prior to delving into Minerva, Marc Beer held several other leadership roles in the field of biopharmaceutical overseeing addressing of rare disease globally, initial public offerings, global growth, acquisitions and more. He has served at numerous companies in leadership positions. He served at ViaCell as the Founding CEO. He also served in the Erytech Pharma board of directors as a member. Additionally, he held multiple positions at Genzyme, the most prominent one being Vice President of Global Marketing. He is an alumnus of Miami University and a holder of a BS. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html